{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T01:20:07Z","timestamp":1789089607023,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","issue":"8-9","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.humimm.2022.07.004","type":"journal-article","created":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T07:11:26Z","timestamp":1658819486000},"page":"628-636","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Expression level of immune checkpoint inhibitory factors in preeclampsia"],"prefix":"10.1016","volume":"83","author":[{"given":"Sahar","family":"Madadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Mohammadinejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Alizadegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Hojjat-Farsangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanam","family":"Dolati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Samadi Kafil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhad","family":"Jadidi-Niaragh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Sadegh","family":"Soltani-Zangbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roza","family":"Motavalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalal","family":"Etemadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shadi","family":"Eghbal-Fard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leili","family":"Aghebati-Maleki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahla","family":"Danaii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simin","family":"Taghavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9823-5454","authenticated-orcid":false,"given":"Mehdi","family":"Yousefi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2022.07.004_b0005","doi-asserted-by":"crossref","first-page":"973","DOI":"10.3389\/fphys.2018.00973","article-title":"Preeclampsia: novel mechanisms and potential therapeutic approaches","volume":"9","author":"Armaly","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.humimm.2022.07.004_b0010","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.biopha.2017.08.077","article-title":"Natural killer T cells in Preeclampsia: An updated review","volume":"95","author":"Hashemi","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.humimm.2022.07.004_b0015","first-page":"95","article-title":"Angiotensin type 2 receptor gene polymorphisms and susceptibility to preeclampsia","volume":"19","author":"Soltani-Zangbar","year":"2018","journal-title":"J. Reproduct Infert."},{"issue":"7","key":"10.1016\/j.humimm.2022.07.004_b0020","first-page":"1205","article-title":"Sarquis ALJTJoM-F, Medicine N: How does preeclampsia affect neonates?","volume":"32","author":"Marins","year":"2019","journal-title":"Highlight. Disease\u2019s Immun."},{"issue":"3","key":"10.1016\/j.humimm.2022.07.004_b0025","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1002\/jcb.27666","article-title":"Investigation of follicular helper T cells, as a novel player, in preeclampsia","volume":"120","author":"Heydarlou","year":"2019","journal-title":"J. Cellul. Biochem."},{"issue":"4","key":"10.1016\/j.humimm.2022.07.004_b0030","first-page":"386","article-title":"Preeclampsia: pathogenesis, prevention, and long-term complications. Seminars in nephrology","volume":"37","author":"Jim","year":"2017","journal-title":"Elsevier"},{"issue":"2","key":"10.1016\/j.humimm.2022.07.004_b0035","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/MNH.0000000000000105","article-title":"Pathogenesis of preeclampsia","volume":"24","author":"Sircar","year":"2015","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"1","key":"10.1016\/j.humimm.2022.07.004_b0040","first-page":"56","article-title":"Maternal mortality from preeclampsia\/eclampsia. Seminars in perinatology","volume":"36","author":"Ghulmiyyah","year":"2012","journal-title":"Elsevier"},{"key":"10.1016\/j.humimm.2022.07.004_b0045","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/AOG.0000000000000472","article-title":"Maternal morbidity associated with early-onset and late-onset preeclampsia","volume":"124","author":"Lisonkova","year":"2014","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.humimm.2022.07.004_b0050","doi-asserted-by":"crossref","first-page":"103317","DOI":"10.1016\/j.jri.2021.103317","article-title":"A new approach to the preeclampsia puzzle; MicroRNA-326 in CD4+ lymphocytes might be as a potential suspect","volume":"145","author":"Zolfaghari","year":"2021","journal-title":"J. Reprod. Immunol."},{"issue":"4","key":"10.1016\/j.humimm.2022.07.004_b0055","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1161\/HYPERTENSIONAHA.107.107607","article-title":"Placental origins of preeclampsia: challenging the current hypothesis","volume":"51","author":"Huppertz","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.humimm.2022.07.004_b0060","doi-asserted-by":"crossref","unstructured":"Cornelius DCJCmiBd: Preeclampsia: from inflammation to immunoregulation. 2018;11:1179545X17752325.","DOI":"10.1177\/1179545X17752325"},{"key":"10.1016\/j.humimm.2022.07.004_b0065","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1600-0897.2010.00836.x","article-title":"The immune system in pregnancy: a unique complexity","volume":"63","author":"Mor","year":"2010","journal-title":"Am. J. Reprod. Immunol."},{"issue":"4","key":"10.1016\/j.humimm.2022.07.004_b0070","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1080\/08820139.2021.1909061","article-title":"Fetomaternal immune tolerance: crucial mechanisms of tolerance for successful pregnancy in humans","volume":"51","author":"Yousefzadeh","year":"2022","journal-title":"Immunol. Invest."},{"issue":"4","key":"10.1016\/j.humimm.2022.07.004_b0075","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1177\/1933719112450330","article-title":"Innate immunity, decidual cells, and preeclampsia","volume":"20","author":"Yeh","year":"2013","journal-title":"Reproduct. Sci."},{"issue":"9","key":"10.1016\/j.humimm.2022.07.004_b0080","doi-asserted-by":"crossref","first-page":"6561","DOI":"10.1002\/jcp.26604","article-title":"Regulatory T and T helper 17 cells: Their roles in preeclampsia","volume":"233","author":"Hosseini","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"4","key":"10.1016\/j.humimm.2022.07.004_b0085","doi-asserted-by":"crossref","first-page":"5106","DOI":"10.1002\/jcp.27315","article-title":"The imbalance of Th17\/Treg axis involved in the pathogenesis of preeclampsia","volume":"234","author":"Eghbal\u2010Fard","year":"2019","journal-title":"J. Cellul. Physiol."},{"key":"10.1016\/j.humimm.2022.07.004_b0090","unstructured":"Anvari F, DABAGH GF, SOLTANI ZMS, KAMALI SE, MALEK HZ, GHARESI FB. 2015. Investigating the association of IL-17A and IL-17F with susceptibility to pre-eclampsia in Iranian women."},{"issue":"4","key":"10.1016\/j.humimm.2022.07.004_b0095","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1080\/08820139.2021.1904976","article-title":"TIGIT and CD155 as Immune-Modulator Receptor and Ligand on CD4+ T cells in Preeclampsia Patients","volume":"51","author":"Kamrani","year":"2022","journal-title":"Immunol. Invest."},{"key":"10.1016\/j.humimm.2022.07.004_b0100","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jri.2017.10.048","article-title":"Early pregnancy immune biomarkers in peripheral blood may predict preeclampsia","volume":"125","author":"Salazar Garcia","year":"2018","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.humimm.2022.07.004_b0105","doi-asserted-by":"crossref","unstructured":"Rahimzadeh M, Norouzian M, Arabpour F, Naderi NJEroci: Regulatory T-cells and preeclampsia: an overview of literature. 2016;12:209.","DOI":"10.1586\/1744666X.2016.1105740"},{"key":"10.1016\/j.humimm.2022.07.004_b0110","doi-asserted-by":"crossref","unstructured":"Zhang YH, Sun HXJEJoI. 2020. Immune checkpoint molecules in pregnancy: focus on regulatory T cells. 50. 160.","DOI":"10.1002\/eji.201948382"},{"key":"10.1016\/j.humimm.2022.07.004_b0115","doi-asserted-by":"crossref","first-page":"103208","DOI":"10.1016\/j.jri.2020.103208","article-title":"Immune checkpoint molecules on T cell subsets of pregnancies with preeclampsia and gestational diabetes mellitus","volume":"142","author":"Zhao","year":"2020","journal-title":"J. Reprod. Immunol."},{"issue":"11","key":"10.1016\/j.humimm.2022.07.004_b0120","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.autrev.2013.05.003","article-title":"Recent insights into the role of the PD-1\/PD-L1 pathway in immunological tolerance and autoimmunity","volume":"12","author":"Gianchecchi","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.humimm.2022.07.004_b0125","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.molimm.2021.06.001","article-title":"Reduction and exhausted features of T lymphocytes under serological changes, and prognostic factors in COVID-19 progression","volume":"138","author":"Mahmoodpoor","year":"2021","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.humimm.2022.07.004_b0130","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/ni.2762","article-title":"A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application","volume":"14","author":"Okazaki","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.humimm.2022.07.004_b0135","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3390\/medicina58020157","article-title":"The role of the immune checkpoint molecules PD-1\/PD-L1 and TIM-3\/Gal-9 in the pathogenesis of preeclampsia\u2014a narrative review","volume":"58","author":"Mittelberger","year":"2022","journal-title":"Medicina"},{"key":"10.1016\/j.humimm.2022.07.004_b0140","doi-asserted-by":"crossref","unstructured":"Li Y, Zhang J, Zhang D, Hong X, Tao Y, Wang S et al. 2017. Tim-3 signaling in peripheral NK cells promotes maternal-fetal immune tolerance and alleviates pregnancy loss. Doi: 10:eaah4323.","DOI":"10.1126\/scisignal.aah4323"},{"key":"10.1016\/j.humimm.2022.07.004_b0145","doi-asserted-by":"crossref","unstructured":"Zhang T, Zhao Y, Cheung WC, Gan YH, Huang L, Li M et al. 2022. Serial changes in two immune checkpoint receptors and ligands, Tim\u20103\/Gal\u20109 and PD\u20101\/PD\u2010L1 in peripheral blood prior to miscarriage: Comparison with pregnancies resulting in a live birth. 87:e13524.","DOI":"10.1111\/aji.13524"},{"key":"10.1016\/j.humimm.2022.07.004_b0150","article-title":"Involvement of the Tim-3 Pathway in the Pathogenesis of Pre-Eclampsia","volume":"1","author":"Wang","year":"2021","journal-title":"Reproduct. Sci."},{"key":"10.1016\/j.humimm.2022.07.004_b0155","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejogrb.2015.08.022","article-title":"Upregulation of the Tim-3\/Gal-9 pathway and correlation with the development of preeclampsia","volume":"194","author":"Hao","year":"2015","journal-title":"Europ. J. Obstet. Gynecol. Reproduct. Biol."},{"key":"10.1016\/j.humimm.2022.07.004_b0160","doi-asserted-by":"crossref","first-page":"e1738","DOI":"10.1038\/cddis.2015.112","article-title":"PD-1 and Tim-3 pathways are associated with regulatory CD8+ T-cell function in decidua and maintenance of normal pregnancy","volume":"6","author":"Wang","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.humimm.2022.07.004_b0165","doi-asserted-by":"crossref","unstructured":"Joller N, Kuchroo VKJECTICiC. 2017. Autoimmunity: Tim-3, Lag-3, and TIGIT. 127","DOI":"10.1007\/82_2017_62"},{"key":"10.1016\/j.humimm.2022.07.004_b0170","doi-asserted-by":"crossref","first-page":"846","DOI":"10.3389\/fimmu.2019.00846","article-title":"Immune checkpoint molecules in reproductive immunology","volume":"10","author":"Miko","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2022.07.004_b0175","doi-asserted-by":"crossref","first-page":"ix","DOI":"10.3109\/10641950109152635","article-title":"The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP)","volume":"20","author":"Brown","year":"2001","journal-title":"Hypertens. Pregn."},{"key":"10.1016\/j.humimm.2022.07.004_b0180","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.preghy.2014.02.001","article-title":"The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP","volume":"4","author":"Tranquilli","year":"2014","journal-title":"Pregn. Hypertension"},{"key":"10.1016\/j.humimm.2022.07.004_b0185","article-title":"Review of the immune mechanisms of preeclampsia and the potential of immune modulating therapy","author":"Ai-ris","year":"2021","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2022.07.004_b0190","doi-asserted-by":"crossref","unstructured":"Qin S, Xu L, Yi M, Yu S, Wu K, Luo SJMc. 2019. Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4. 18:1.","DOI":"10.1186\/s12943-019-1091-2"},{"key":"10.1016\/j.humimm.2022.07.004_b0195","doi-asserted-by":"crossref","unstructured":"Wang S, Sun F, Li M, Qian J, Chen C, Wang M. et al. 2019. The appropriate frequency and function of decidual Tim-3+ CTLA-4+ CD8+ T cells are important in maintaining normal pregnancy. 10:1.","DOI":"10.1038\/s41419-019-1642-x"},{"key":"10.1016\/j.humimm.2022.07.004_b0200","first-page":"99","article-title":"CTLA-4, an essential immune-checkpoint for T-cell activation. Emerging Concepts Targeting Immune Checkpoints in Cancer and Autoimmunity","author":"Chikuma","year":"2017","journal-title":"Springer"},{"key":"10.1016\/j.humimm.2022.07.004_b0205","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jri.2018.11.002","article-title":"T cell subsets in peripheral blood of women with recurrent implantation failure","volume":"131","author":"Ghaebi","year":"2019","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.humimm.2022.07.004_b0210","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/aji.12410","article-title":"Regulatory T-cell subpopulations in severe or early-onset preeclampsia","volume":"74","author":"Boij","year":"2015","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.humimm.2022.07.004_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2020.103208","article-title":"Immune checkpoint molecules on T cell subsets of pregnancies with preeclampsia and gestational diabetes mellitus","volume":"142","author":"Zhao","year":"2020","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.humimm.2022.07.004_b0220","first-page":"1","article-title":"The PD-1\/PD-L1 inhibitory pathway is altered in pre-eclampsia and regulates T cell responses in pre-eclamptic rats","volume":"6","author":"Tian","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.humimm.2022.07.004_b0225","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/aji.12365","article-title":"Recent insight into the role of the PD-1\/PD-L1 pathway in feto-maternal tolerance and pregnancy","volume":"74","author":"Zhang","year":"2015","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.humimm.2022.07.004_b0230","doi-asserted-by":"crossref","unstructured":"Meggyes M, Nagy DU, Szereday LJJoCM 2020. Investigation of the PD-1 and PD-L1 immune checkpoint molecules throughout healthy human pregnancy and in nonpregnant women. 9. 2536.","DOI":"10.3390\/jcm9082536"},{"key":"10.1016\/j.humimm.2022.07.004_b0235","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/humrep\/dew019","article-title":"Programmed cell death-1 (PD-1) and T-cell immunoglobulin mucin-3 (Tim-3) regulate CD4+ T cells to induce Type 2 helper T cell (Th2) bias at the maternal\u2013fetal interface","volume":"31","author":"Wang","year":"2016","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.humimm.2022.07.004_b0240","doi-asserted-by":"crossref","unstructured":"Meggyes M, Miko E, Szigeti B, Farkas N, Szereday LJBp, 2019. childbirth: The importance of the PD-1\/PD-L1 pathway at the maternal-fetal interface. 19:1.","DOI":"10.1186\/s12884-019-2218-6"},{"key":"10.1016\/j.humimm.2022.07.004_b0245","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1002\/eji.201344392","article-title":"Enhanced suppressor function of TIM-3+ FoxP3+ regulatory T cells","volume":"44","author":"Gautron","year":"2014","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.humimm.2022.07.004_b0250","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/cmi.2014.126","article-title":"The Galectin-9\/Tim-3 pathway is involved in the regulation of NK cell function at the maternal\u2013fetal interface in early pregnancy","volume":"13","author":"Li","year":"2016","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.humimm.2022.07.004_b0255","doi-asserted-by":"crossref","first-page":"e71811","DOI":"10.1371\/journal.pone.0071811","article-title":"Involvement of Galectin-9\/TIM-3 pathway in the systemic inflammatory response in early-onset preeclampsia","volume":"8","author":"Miko","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.humimm.2022.07.004_b0260","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.4049\/jimmunol.1700114","article-title":"Decidual T cells exhibit a highly differentiated phenotype and demonstrate potential fetal specificity and a strong transcriptional response to IFN","volume":"199","author":"Powell","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2022.07.004_b0265","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1084\/jem.20160485","article-title":"The EGR2 targets LAG-3 and 4\u20131BB describe and regulate dysfunctional antigen-specific CD8+ T cells in the tumor microenvironment","volume":"214","author":"Williams","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.humimm.2022.07.004_b0270","article-title":"Immune checkpoints and reproductive immunology: Pioneers in the future therapy of infertility related Disorders?","volume":"99","author":"Khosroshahi","year":"2021","journal-title":"Int. Immunopharmacol."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885922001392?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885922001392?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:55:59Z","timestamp":1759319759000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885922001392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":54,"journal-issue":{"issue":"8-9","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0198885922001392"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2022.07.004","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression level of immune checkpoint inhibitory factors in preeclampsia","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2022.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}